{"database": "openregs", "table": "documents", "rows": [["FDA-2012-D-0307-0018", "FDA", "FDA-2012-D-0307", "Reference 31-McCutcheon_et_al-2011-PloSOne re Amendment to \u2018\u2018Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;\u2019\u2019 Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2017-12-22T05:00:00Z", 2017, 12, null, null, "2020-02-25T15:37:23Z", null, 0, 0, "0900006482d58832"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-D-0307-0018"], "units": {}, "query_ms": 67.5188769819215, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}